These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35695095)

  • 1. Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19.
    Sharma T; Abohashrh M; Baig MH; Dong JJ; Alam MM; Ahmad I; Irfan S
    Saudi J Biol Sci; 2021 May; 28(5):3152-3159. PubMed ID: 33649700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the Mystery of COVID-19 Pathogenesis: Spike Protein and Cu Can Synergize to Trigger ROS Production.
    Katarzyna Lesiów M; Witwicki M; Tan NK; Graziotto ME; New EJ
    Chemistry; 2023 Oct; 29(55):e202301530. PubMed ID: 37414735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of spike genetic variants in vaccines against SARS-CoV-2].
    Reina J; Fraile-Ribot P
    Vacunas; 2021; 22(2):59-61. PubMed ID: 33867900
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID rebound is surprisingly common - even without Paxlovid.
    Callaway E
    Nature; 2022 Aug; ():. PubMed ID: 35953572
    [No Abstract]   [Full Text] [Related]  

  • 5. Re-discussing targeting in times of Covid-19.
    Kaasch A
    Glob Soc Policy; 2022 Dec; 22(3):423-425. PubMed ID: 38603219
    [No Abstract]   [Full Text] [Related]  

  • 6. Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management.
    von Possel R; Menge B; Deschermeier C; Fritzsche C; Hemmer C; Geerdes-Fenge H; Loebermann M; Schulz A; Lattwein E; Steinhagen K; Tönnies R; Ahrendt R; Emmerich P
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing severe COVID-19 outcomes of first and second/third waves: a prospective single-centre cohort study of health-related quality of life and pulmonary outcomes 6 months after infection.
    Darlington P; Roël M; Cronhjort M; Hanna G; Hedman A; Joelsson-Alm E; Schandl A
    BMJ Open; 2023 Jul; 13(7):e071394. PubMed ID: 37460259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghosts of the past: Elemental composition, biosynthesis reactions and thermodynamic properties of Zeta P.2, Eta B.1.525, Theta P.3, Kappa B.1.617.1, Iota B.1.526, Lambda C.37 and Mu B.1.621 variants of SARS-CoV-2.
    Popovic M; Pantović Pavlović M; Pavlović M
    Microb Risk Anal; 2023 Aug; 24():100263. PubMed ID: 37234934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies.
    Bassani D; Moro S
    Molecules; 2023 May; 28(9):. PubMed ID: 37175316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Specific Stem Cell Memory CD8+ T Cells May Indicate a Long-Term Protection against Evolving SARS-CoV-2.
    Aleksova M; Todorova Y; Emilova R; Baymakova M; Yancheva N; Andonova R; Zasheva A; Grifoni A; Weiskopf D; Sette A; Nikolova M
    Diagnostics (Basel); 2023 Mar; 13(7):. PubMed ID: 37046496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics.
    Pavan M; Moro S
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of SARS-CoV-2 recombinants and emerging Omicron sublineages.
    Wang Y; Long Y; Wang F; Li C; Liu W
    Int J Med Sci; 2023; 20(1):151-162. PubMed ID: 36619228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?
    Talotta R
    Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?
    Pavan M; Bassani D; Sturlese M; Moro S
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1704-1714. PubMed ID: 35695095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Surveillance of SARS-CoV-2 M
    Lee JT; Yang Q; Gribenko A; Perrin BS; Zhu Y; Cardin R; Liberator PA; Anderson AS; Hao L
    mBio; 2022 Aug; 13(4):e0086922. PubMed ID: 35862764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Drug Discovery for the Treatment of COVID-19 Infections.
    Ng TI; Correia I; Seagal J; DeGoey DA; Schrimpf MR; Hardee DJ; Noey EL; Kati WM
    Viruses; 2022 May; 14(5):. PubMed ID: 35632703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the SARS-CoV-2 genome and spike protein in the immunopathogenesis of COVID-19 and in the efficacy of vaccines.
    Jiménez-Morales S; Pérez-Amado CJ; Montúfar-Robles I; Fragoso JM; Aranda-Uribe IS; Ramos-Puga DA; Martínez-Flores ÁE; Ramírez-Bello J
    Cir Cir; 2023; 91(2):268-276. PubMed ID: 37084305
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.